To further a connection between CD45 activity and CD38, we interrogated the functional consequences of inhibiting CD38 enzymatic activity using the small molecule inhibitor 78c30,31 in the Th-CLL cell co-culture model (Figure 3A). Here, PTPRC is linked to B-cell chronic lymphocytic leukemia.